Chemocentryx

Discussion in 'Biotech Startups' started by anonymous, Mar 28, 2021 at 6:44 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Today should be telling what will happen with this drug. If delayed then how long will they keep us around before furloughed or just let go?
     

  2. anonymous

    anonymous Guest

    About 5 minutes. Or maybe a day and a half as that will be about us much vacation as we have accrued by then
     
  3. anonymous

    anonymous Guest

    9-9. Panel not impressed
     
  4. anonymous

    anonymous Guest

    Doesn't look to good. Not a very good endorsement even if approved.
     
  5. anonymous

    anonymous Guest

    two yesses and a tie - good news
     
  6. anonymous

    anonymous Guest

    Yes. Even if somehow it is approved in July the label will be very restrictive. CRL likely
     
  7. anonymous

    anonymous Guest

    Even if approved with a severely limited label, the panels interpretation of the data gives payers an out to not cover avacopan. The few patients we find and convince the doc to prescribe it for them won't be able to afford it anyway. I wouldn't be surprised if it is approved for expanded access while we perform an additional study. Either way there will be no revenue flow so no need for us. At least we have 2 months to find new jobs:(
     
  8. anonymous

    anonymous Guest

    Yep, this company is done. Drug may get approved but will have very limited use and revenue generated. I wish they waited till drug was approved before deciding to bring us on board. I left a good stable company although less pay for this, which is on me, but I took a leap of faith and got burned.
     
  9. anonymous

    anonymous Guest

    So, what’s the strike price on YOUR options???!
     
  10. anonymous

    anonymous Guest

    My options are below more water than the Titanic!

    I wish they would’ve issued us PUTs.
     
  11. anonymous

    anonymous Guest

    Time to stop drinking the koolade and switch to something more realistic AND stronger.
    Signed, Your Field Management Team
     
  12. anonymous

    anonymous Guest

    I’m double dipping anyways! No loss for me! I knew this would happen!
     
  13. anonymous

    anonymous Guest

    Less than a 24 hour honeymoon period before we founder out we were married to a lying, two-faced pharma wannabe loser.
     
  14. anonymous

    anonymous Guest

    Yeah no doubt. How’s everyone doing on their first module?!
     
  15. anonymous

    anonymous Guest

    You talking about the CEO? If so, he definitely has blinders on in regards to Avacopan. The signs were there early on that this study design had problems. Going to have to say this company is a joke.
     
  16. anonymous

    anonymous Guest

    Yeah it’s generally not a good idea to ignore FDA recommendations when designing a trial. Arrogance.
     
  17. anonymous

    anonymous Guest

    My resume is updated and out the door!
     
  18. anonymous

    anonymous Guest

    Time to jump to Bayer if it's not too late. Are they still hiring?
     
  19. anonymous

    anonymous Guest

    As long as you dont mind not making $ and being tracked 24/7
     
  20. anonymous

    anonymous Guest

    Abbvie is expanding